# HyperArc Registry Study

> **NCT05270707** · — · COMPLETED · sponsor: **Varian, a Siemens Healthineers Company** · enrollment: 968 (actual)

## Conditions studied

- Brain Metastases
- CNS Neoplasm
- CNS Disorder, Intracranial

## Interventions

- **RADIATION:** Stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT05270707
- **Lead sponsor:** Varian, a Siemens Healthineers Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-31
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 968 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270707, "HyperArc Registry Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05270707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
